NCT02540265View on ClinicalTrials.gov

Placebo-Controlled Evaluation of N1539 Following Bunionectomy Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Pain, Post-operative
Interventions
DRUG

N1539

DRUG

Intravenous Placebo

Trial Locations (1)

Unknown

Chesapeake Research Group, LLC, Pasadena

Sponsors

Lead Sponsor

Baudax Bio
All Listed Sponsors
lead

Baudax Bio

INDUSTRY

NCT02540265 - Placebo-Controlled Evaluation of N1539 Following Bunionectomy Surgery | Biotech Hunter | Biotech Hunter